Skip to main content

Table 2 Analysis of risk factors associated with Uganda II family among sputum smear-positive TB patients in Uganda

From: The Mycobacterium tuberculosisUganda II family and resistance to first-line anti-tuberculosis drugs in Uganda

Risk Factor

 

Proportion n/N (%) N = 961

** Univariate analysis

   

OR (95% CI)

p-value

Sex

Male

279/630 (44.3)

1.12 (0.83-1.52)

0.420

 

Female

143/343 (41.7)

Ref.

 

Age

15-24

71/189 (37.6)

Ref.

 
 

13-14

10/21 (47.6)

0.66 (0.25-1.72)

0.386

 

25-34

159/330 (48.2)

0.65 (0.45-9.20)

0.017

 

35-44

96/235 (40.9)

0.87 (0.62-1.21)

0.406

 

45-54

45/100 (45.0)

0.74 (0.46- 1.19)

0.210

 

>55

35/86 (40.7)

0.87 (0.47-1.60)

0.660

Zone

South West

172/313 (55.0)

Ref.

 
 

Kampala

112/278(40.3)

0.55 (0.36-0.83)

0.006

 

Eastern

22/89 (24.7)

0.26 (0.17-0.41)

<0.001

 

South East

7/36 (19.40)

0.20 (0.14-0.28)

<0.001

 

North East

26/59 (44.1)

0.64 (0.35-1.17)

0.146

 

North

10/28 (35.7)

0.45 (0.31-0.64)

<0.001

 

North West

20/66 (30.3)

0.32 (0.18-0.55)

<0.001

 

Western

53/104 (51.0)

0.86 (0.43-1.72)

0.667

Previously treated for TB

Yes

31/78 (39.7)

0.85 (0.58-1.25)

0.403

HIV status

Positive

130/442 (29.4)

1.09(0.73-1.63)

0.648

Diagnosis made in an urban setting

Yes

267/585 (45.6)

0.80 (0.49-1.32)

0.385

  1. ** Odds ratios and confidence intervals adjusted for cluster design.